Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT05792280

Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning

Led by The Third Xiangya Hospital of Central South University · Updated on 2025-03-13

180

Participants Needed

1

Research Sites

222 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in mediastinal ultrasound endoscopic scanning. The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2. Whether the artificial intelligence system can improve the integrity and efficiency of the mediastinum scanning for the ultrasound endoscopist. Participants will undergo mediastinal EUS with or without the assistance of the artificial intelligence system.

CONDITIONS

Official Title

Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older and younger than 80 years
  • Patients who require endoscopic ultrasonography
  • Agree to participate and sign the informed consent form
Not Eligible

You will not qualify if you...

  • Poor physical condition including hemoglobin ≤8.0 g/dl or severe cardiopulmonary insufficiency
  • Failed anesthesia assessment
  • Pregnancy or breastfeeding
  • Acute stage of chemical or corrosive injury with risk of perforation
  • Recent acute coronary syndrome or unstable ischemic heart attack
  • Heart diseases such as right-to-left shunt, severe pulmonary hypertension (pulmonary artery pressure > 90 mmHg), uncontrolled systemic hypertension, or adult respiratory distress syndrome
  • Refusal to participate in the study
  • Prior surgery, radiotherapy, or chemotherapy for mediastinal lesions
  • Mental illness, drug addiction, inability to communicate, or other conditions affecting follow-up or study results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China, 410013

Actively Recruiting

Loading map...

Research Team

X

Xiaoyan Wang, Doctor

CONTACT

S

Shiqin Huang, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here